Skip to Content Skip to Navigation

Connecting global innovation with AgriFutures growAG.

Finding world-leading agrifood research expertise, and research, investment and commercialisation opportunities easily, let alone in one easy-to-use location, was always a challenge – until AgriFutures growAG..

John Harvey, Managing Director of AgriFutures Australia, Fern Ho, Co-founder and CEO of Leaf Protein Co and Craig Baille, from the University of Queensland in discussion at evokeAG 2023.

Finding world-leading agrifood research expertise, and research, investment and commercialisation opportunities easily, let alone in one easy-to-use location, has always been a challenge – until AgriFutures growAG..

growAG. is helping to connect its users, researchers, investors, innovators, thought leaders and commercial partners from around Australia and across the globe with agrifood innovation, expertise and opportunities. By shortening the time it can take to find and connect with strategic partners, its’ helping increase dealflow and drive value on-farm through the development and adoption of game changing technologies.

In this episode, we’re bringing you a conversation recorded live at evokeAG. 2023 around accelerating commercialisation with AgriFutures growAG.

Professor Craig Baille, the former Head of School and Dean for Agriculture and Environmental Science from the University of Southern Queensland and Fern Ho, the Co-founder and CEO of Leaf Protein Co have both used the platform with tremendous success.

Listen to their stories, together with insights from John Harvey - the Managing Director of AgriFutures Australia.

For more information on the growAG. platform, including more success stories and current investment opportunities, please visit growag.com.

Click here, for early bird tickets. Now on sale for AgriFutures evokeAG. 2024. 

Looking for engagement?

Showcase your commercialisation opportunity today.

Talk to our team to discuss how growAG. can connect your innovation to industry.

Have questions? Find answers to our most frequently asked questions on research projects, commercial opportunities, organisations and more.